|
EIF2B1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.557800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.481900E-03 |
| Normal-vs-Stage2 |
1.218990E-01 |
| Normal-vs-Stage3 |
5.813600E-04 |
| Normal-vs-Stage4 |
5.358700E-03 |
| Stage1-vs-Stage2 |
7.240800E-01 |
| Stage1-vs-Stage3 |
2.568800E-01 |
| Stage1-vs-Stage4 |
4.811800E-01 |
| Stage2-vs-Stage3 |
3.042200E-01 |
| Stage2-vs-Stage4 |
4.314400E-01 |
| Stage3-vs-Stage4 |
8.803200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.578700E-04 |
| Normal-vs-AfricanAmerican |
2.664200E-01 |
| Normal-vs-Asian |
5.664000E-01 |
| Caucasian-vs-AfricanAmerican |
5.432000E-01 |
| Caucasian-vs-Asian |
7.199700E-02 |
| AfricanAmerican-vs-Asian |
5.016800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.343270E-03 |
| Normal-vs-Female |
1.275240E-03 |
| Male-vs-Female |
5.974600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.000300E-03 |
| Normal-vs-Age(41-60Yrs) |
9.027900E-04 |
| Normal-vs-Age(61-80Yrs) |
7.138600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.026360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.156800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.187200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.192800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.555200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.606400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.843800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.856050E-01 |
| Classical-VS-Follicular |
4.609900E-02 |
| Classical-VS-Other |
3.073600E-01 |
| Classical-VS-Normal |
5.096100E-02 |
| Tall-VS-Follicular |
6.791600E-01 |
| Tall-VS-Other |
7.598200E-01 |
| Tall-VS-Normal |
1.012260E-02 |
| Follicular-VS-Other |
9.625000E-01 |
| Follicular-VS-Normal |
2.002600E-03 |
| Other-VS-Normal |
6.436200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.848200E-04 |
| Normal-vs-N1 |
4.079000E-03 |
| N0-vs-N1 |
7.225600E-01 |
|
|
